关注
Stella Zawedde-Muyanja
Stella Zawedde-Muyanja
Research Scientist, The Infectious Diseases Institute, College of Health Sciences, Makerere University
在 idi.co.ug 的电子邮件经过验证
标题
引用次数
引用次数
年份
Decentralisation of child tuberculosis services increases case finding and uptake of preventive therapy in Uganda
S Zawedde-Muyanja, A Nakanwagi, JP Dongo, MP Sekadde, ...
The international journal of tuberculosis and lung disease 22 (11), 1314-1321, 2018
832018
Risk factors for mortality among patients diagnosed with multi-drug resistant tuberculosis in Uganda-a case-control study
E Kizito, J Musaazi, K Mutesasira, F Twinomugisha, H Namwanje, ...
BMC infectious diseases 21, 1-7, 2021
262021
Estimating the effect of pretreatment loss to follow up on TB associated mortality at public health facilities in Uganda
S Zawedde-Muyanja, J Musaazi, YC Manabe, A Katamba, JI Nankabirwa, ...
PLoS One 15 (11), e0241611, 2020
212020
Rapid improvement in passive tuberculosis case detection and tuberculosis treatment outcomes after implementation of a bundled laboratory diagnostic and on-site training …
YC Manabe, S Zawedde-Muyanja, SM Burnett, F Mugabe, S Naikoba, ...
Open forum infectious diseases 2 (1), ofv030, 2015
212015
Implementation of an effective decentralised programme for detection, treatment and prevention of tuberculosis in children
JP Dongo, SM Graham, J Nsonga, F Wabwire-Mangen, ...
Tropical Medicine and Infectious Disease 6 (3), 131, 2021
182021
Effect of TB/HIV integration on TB and HIV indicators in rural Ugandan health facilities
SM Burnett, S Zawedde-Muyanja, SM Hermans, MR Weaver, ...
JAIDS Journal of Acquired Immune Deficiency Syndromes 79 (5), 605-611, 2018
182018
Provision of decentralized TB care services: A Detect–Treat–Prevent Strategy for children and adolescents affected by TB
S Zawedde-Muyanja, A Reuter, MA Tovar, H Hussain, A Loando Mboyo, ...
Pathogens 10 (12), 1568, 2021
17*2021
Decreasing trends of bacteraemia among HIV‐infected Ugandan adults: incidence, aetiology, clinical outcomes and effect of antiretroviral therapy in a semi‐urban setting (2000–2008)
SZ Muyanja, N Larke, D Rutebarika, I Kaddu, S Nakubulwa, J Levin, ...
Tropical Medicine & International Health 16 (6), 756-765, 2011
142011
Xpert® MTB/RIF associated with improved treatment initiation among patients with smear-negative tuberculosis
S Zawedde-Muyanja, YC Manabe, NK Sewankambo, L Nakiyingi, ...
The International Journal of Tuberculosis and Lung Disease 22 (12), 1475-1480, 2018
132018
Ending tuberculosis in a post-COVID-19 world: a person-centred, equity-oriented approach
T Ryckman, K Robsky, L Cilloni, S Zawedde-Muyanja, R Ananthakrishnan, ...
The Lancet Infectious Diseases 23 (2), e59-e66, 2023
102023
Developing a patient-centered community-based model for management of multi-drug resistant tuberculosis in Uganda: a discrete choice experiment
R Makabayi-Mugabe, J Musaazi, S Zawedde-Muyanja, E Kizito, ...
BMC health services research 22 (1), 154, 2022
92022
Effect of on-site support on laboratory practice for human immunodeficiency virus, tuberculosis, and malaria testing
SM Burnett, MK Mbonye, R Martin, A Ronald, S Zawedde-Muyanja, ...
American journal of clinical pathology 146 (4), 469-477, 2016
92016
Patient and health system factors associated with pretreatment loss to follow up among patients diagnosed with tuberculosis using Xpert® MTB/RIF testing in Uganda
S Zawedde-Muyanja, A Katamba, A Cattamanchi, B Castelnuovo, ...
BMC public health 20, 1-8, 2020
82020
Increased uptake of tuberculosis preventive therapy (TPT) among people living with HIV following the 100-days accelerated campaign: A retrospective review of routinely …
J Musaazi, C Sekaggya-Wiltshire, S Okoboi, S Zawedde-Muyanja, ...
PloS one 18 (2), e0268935, 2023
72023
Patient and health system level barriers to and facilitators for tuberculosis treatment initiation in Uganda: a qualitative study
S Zawedde-Muyanja, YC Manabe, A Cattamanchi, B Castelnuovo, ...
BMC health services research 22 (1), 831, 2022
72022
Effect of educational outreach timing and duration on facility performance for infectious disease care in Uganda: a trial with pre-post and cluster randomized controlled components
SM Burnett, MK Mbonye, S Naikoba, S Zawedde-Muyanja, SN Kinoti, ...
Plos one 10 (9), e0136966, 2015
72015
Comparing adherence to MDR-TB treatment among patients on self-administered therapy and those on directly observed therapy: non-inferiority randomized controlled trial
C Wekesa, C Sekaggya-Wiltshire, SZ Muyanja, I Lume, MS Nabaggala, ...
Trials 24 (1), 326, 2023
52023
Anti‐retroviral therapy scale‐up and its impact on sex‐stratified tuberculosis notification trends in Uganda
S Zawedde‐Muyanja, YC Manabe, J Musaazi, FR Mugabe, JM Ross, ...
African Journal of Reproduction and Gynaecological Endoscopy 22 (9), 2019
52019
Risk factors for disruptions in tuberculosis care in Uganda during the COVID-19 pandemic
PD Jackson, SZ Muyanja, I Sekitoleko, M Bbuye, M Helwig, R Padalkar, ...
PLOS global public health 3 (6), e0001573, 2023
42023
Health Equity and Respiratory Diseases in Low-and Middle-Income Countries
TS Peter Jackson, Stella Zawedde-Muyanja
Clinics in Chest Medicine, 2023
42023
系统目前无法执行此操作,请稍后再试。
文章 1–20